EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression

Gülfizar Sözeri-Varma, Nalan Kalkan-Oğuzhanoglu, Muharrem Efe, Yılmaz Kıroglu, Taçlan Duman

Neuropsychiatric Disease and Treatment · 2013-08 · 1053

DOI: 10.2147/ndt.s42627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychiatric Disease and Treatment, 2013-08. Verfasst von Gülfizar Sözeri-Varma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Pamukkale University, Denizli, Turkey. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Previous studies have determined the neurochemical metabolite abnormalities in major depressive disorder (MDD). The results of studies are inconsistent. Severity of depression may relate to neurochemical metabolic changes. The aim of this study is to investigate neurochemical metabolite levels in the prefrontal cortex (PFC) of patients with mild/moderate MDD. METHODS: Twenty-one patients with mild MDD, 18 patients with moderate MDD, and 16 matched control subjects participated in the study. Patients had had their first episode. They had not taken treatment. The severity of depression was assessed by the Hamilton Rating Scale for Depression (HAM-D). Levels of N-acetyl aspartate (NAA), choline-containing compounds (Cho), and creatine-containing compounds (Cr) were measured using proton magnetic resonance spectroscopy (1H-MRS) at 1.5 T, with an 8-cm(3) single voxel placed in the right PFC. RESULTS: The moderate MDD patients had lower NAA/Cr levels than the control group. No differences were found in neurochemical metabolite levels between the mild MDD and control groups. No correlation was found between the patients' neurochemical metabolite levels and HAM-D scores. CONCLUSION: Our findings suggest that NAA/Cr levels are low in moderate-level MDD in the PFC. Neurochemical metabolite levels did not change in mild depressive disorder. Our results suggest that the severity of depression may affect neuronal function and viability. Studies are needed to confirm this finding, including studies on severely depressive patients.

Schlagwörter

Stichwörter der Autor:innen

N-acetyl aspartatecholinecreatinemagnetic resonance spectroscopymajor depressive disorder

Autor:innen und Institutionen

  • Department of Psychiatry, Pamukkale University, Denizli, Turkey.

Zitieren

APA

Sözeri-Varma, G., Kalkan-Oğuzhanoglu, N., Efe, M., Kıroglu, Y., & Duman, T. (2013). Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression. Neuropsychiatric Disease and Treatment, 1053. https://doi.org/10.2147/ndt.s42627

Vancouver

Sözeri-Varma G, Kalkan-Oğuzhanoglu N, Efe M, Kıroglu Y, Duman T. Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression. Neuropsychiatric Disease and Treatment. 2013:1053. doi:10.2147/ndt.s42627

BibTeX
@article{SzeriVarma2013,
  author = {Sözeri-Varma, Gülfizar and Kalkan-Oğuzhanoglu, Nalan and Efe, Muharrem and Kıroglu, Yılmaz and Duman, Taçlan},
  title = {Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression},
  journal = {Neuropsychiatric Disease and Treatment},
  year = {2013},
  pages = {1053},
  doi = {10.2147/ndt.s42627}
}
Kostenlos starten →